Founded by UCSF scientists and Stanford and Cambridge technologists, our mission is using big data to understand the human microbiome. We’re all covered in trillions of bacteria. We help consumers and organizations understand what they are and what they do. We're using tools like machine learning, bioinformatics, crowdsourcing, Illumina Hi-Seq, and robots.
uBiome addresses a massive need: dozens of conditions are correlated with the human microbiome (asthma, diabetes, irritable bowel, heart disease, etc.). We are the first and only big data company focused on the microbiome.
Our product accomplishes two goals: 1) allowing consumers access to their microbiome to learn about their bodies, perform experiments, and see how current studies apply to them 2) allowing organizations to learn about the microbiome at scale.
Our current investors include Georges Harik (employee #9 at Google) and other Silicon Valley angels, and we are proud members of 500 Startups.
Our technology consists of a self-sampling kit for the microbiome (including swab and tube with sample stabilization buffers), easy-to-follow instructions and survey instruments about personal characteristics, health condition, and disease course. The samples are then mailed (as exempt specimens) back to our lab for 16s rRNA sequencing and data analysis including phylogenetic placement, correlations, and machine learning.
We are building this business because we want to 1) learn more about the microbiome and how it affects our bodies and derive all of the value from the transformation that understanding will create 2) change the way scientific research is done so that it is more scalable, collaborative with the public, and uses modern machine learning and data analysis techniques.
Active UsersJuly 2013